University of Washington, Medicine Eye Institute
Welcome,         Profile    Billing    Logout  
 2 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Luttrell, Ian
ADVISE, NCT03828019: Adalimumab vs. Conventional Immunosuppression for Uveitis Trial

Active, not recruiting
3
222
Europe, Canada, US, RoW
Adalimumab (ADA), Adalimumab, Humira, Conventional immunosuppression (CON), Azathioprine, Imuran , Cyclosporine, Methotrexate, Rheumatrex, Mycophenolate, CellCept, Cyclosporine, Sandimmune, Neoral, Tacrolimus, Prograf
JHSPH Center for Clinical Trials
Uveitis
04/24
09/24
Pepple, Kathryn
ADVISE, NCT03828019: Adalimumab vs. Conventional Immunosuppression for Uveitis Trial

Active, not recruiting
3
222
Europe, Canada, US, RoW
Adalimumab (ADA), Adalimumab, Humira, Conventional immunosuppression (CON), Azathioprine, Imuran , Cyclosporine, Methotrexate, Rheumatrex, Mycophenolate, CellCept, Cyclosporine, Sandimmune, Neoral, Tacrolimus, Prograf
JHSPH Center for Clinical Trials
Uveitis
04/24
09/24

Download Options